Clinical Efficacy and Safety of NK and NKT Cells Infusion in Patients With Non Small Cell Lung Cancer

计划入组 30 人 · 首次发布于 2017 年 6 月 26 日

A Phase I Single-arm Clinical Study of Donor NK Cells Infusion Combined With Low-dose Interleukin-2 in the Treatment of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation.

计划入组 12 人 · 首次发布于 2024 年 10 月 15 日

DC/NK Cell Therapy

计划入组 10 人 · 首次发布于 2025 年 10 月 2 日

NK/NKT cell therapy

NKTT-320

NK cell therapy

Gamida Cell

Israel

GAMIDA CELL INC.

United States

CELL GENESYS INC.

United States

Stereotactic Ablative Radiotherapy Shows Promise in Pancreatic Cancer Treatment, While Phase 3 Trial Questions Chemoradiation Benefits

GRI Bio Secures Patent Protection for Novel NKT Cell-Targeting Compounds Across Inflammatory Diseases

Cellistic Launches Echo-NK Platform for Scalable Allogeneic NK Cell Therapy Manufacturing